Assessment of Glucocerebrosidase Enzyme Activity in Parkinson Disease Using Multiple Approaches

Mov Disord. 2022 Mar;37(3):655-656. doi: 10.1002/mds.28951. Epub 2022 Feb 1.

Authors

Roberto A Ortega¹, Olaf Bodamer^{2

3}, Roy W A Peake⁴, Deborah Raymond¹, Susan B Bressman¹, Rachel Saunders-Pullman¹

Affiliations

¹ Department of Neurology, Mount Sinai Beth Israel, and Icahn School of Medicine, New York, New York, USA.
² Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
³ Harvard Medical School, Boston, Massachusetts, USA.
⁴ Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Gaucher Disease*
Glucosylceramidase / genetics
Humans
Parkinson Disease* / enzymology
alpha-Synuclein

Substances

alpha-Synuclein
Glucosylceramidase

Grants and funding